[IMCAS World 2026 Special] Shaping the Future: K-Medical Aesthetics Leading Innovation ㉚ | Interview with Dr. Hosung Choi, KOL for P198 ExoHealer & ExoNature
Primoris International continued its active global expansion at IMCAS World Congress 2026 in Paris, led by its P198 exosome skin booster line. We spoke with Dr. Hosung Choi (LIEUL Clinic, Seoul), who served as a speaker at the company's open lecture at the booth to share his clinical experience. P198 comprises two products: ExoHealer, based on umbilical cord blood stem cell-derived exosomes, and ExoNature, based on Panax ginseng-derived plant exosomes. Dr. Choi noted that "the more I learned, the more I realized how much exosome quality matters," explaining why he chose UCB-derived P198. His presentation drew particular attention for introducing lip rejuvenation as a novel indication, and he emphasized that "the anti-inflammatory effect is what makes exosomes truly stand out among skin boosters." He also observed that "the influence of K-Beauty is not fading — it is only getting stronger," crediting Korea's manufacturing excellence for the expansion of the global skin booster market.
#MedicalAestheticNews #IMCAS2026 #PrimorisInternational #P198ExoHealer #P198ExoNature #Exosome #DrHosungChoi #LIEULClinic
★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11291

Comments
Post a Comment